United States (US) Gliflozin Market (2025-2031) | Companies, Analysis, Size & Revenue, Growth, Competitive Landscape, Share, Outlook, Segmentation, Value, Industry, Trends, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Gliflozin Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Gliflozin Market - Industry Life Cycle

3.4 United States (US) Gliflozin Market - Porter's Five Forces

3.5 United States (US) Gliflozin Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Gliflozin Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in the United States

4.2.2 Growing awareness about the benefits of SGLT-2 inhibitors like gliflozin

4.2.3 Favorable reimbursement policies for diabetes medications in the US

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval and marketing

4.3.2 Potential side effects and safety concerns associated with SGLT-2 inhibitors

4.3.3 Competition from other classes of diabetes medications

6.1 United States (US) Gliflozin Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Gliflozin Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Gliflozin Market Revenues & Volume, By Dapagliflozin, 2021- 2031F

6.1.4 United States (US) Gliflozin Market Revenues & Volume, By Canagliflozin, 2021- 2031F

6.1.5 United States (US) Gliflozin Market Revenues & Volume, By Empagliflozin, 2021- 2031F

6.1.6 United States (US) Gliflozin Market Revenues & Volume, By Other, 2021- 2031F

6.2 United States (US) Gliflozin Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Gliflozin Market Revenues & Volume, By Hospital, 2021- 2031F

6.2.3 United States (US) Gliflozin Market Revenues & Volume, By Clinic, 2021- 2031F

6.2.4 United States (US) Gliflozin Market Revenues & Volume, By Other, 2021- 2031F

7.1 United States (US) Gliflozin Market Export to Major Countries

7.2 United States (US) Gliflozin Market Imports from Major Countries

8.1 Prescription refill rates for gliflozin in the US

8.2 Number of new patients prescribed gliflozin each quarter

8.3 Patient adherence rates to gliflozin treatment

8.4 Number of clinical trials and research studies conducted on gliflozin efficacy and safety

8.5 Adoption rates of gliflozin by different healthcare providers and institutions

9.1 United States (US) Gliflozin Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Gliflozin Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Gliflozin Market Revenue Share, By Companies, 2024

10.2 United States (US) Gliflozin Market Competitive Benchmarking, By Operating and Technical Parameters